companydata.dkENDOGEN ApS: Financial statements 2023
CVR: 29813337
ENDOGEN ApS (CVR 29813337) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -18,958 and a net result of DKK -18,958 compared with DKK -15,405 the year before. Equity amounted to DKK 20,010. The solvency ratio was 16%. The company had 1 employee in the financial year.
- Gross Profit
- -18,958 kr.
- Profit/Loss
- -18,958 kr.
- Equity
- 20,010 kr.
- Total Assets
- 125,226 kr.
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -19 t. | -19 t. | 20 t. | 1 |
| 2022 | - | -15 t. | -15 t. | 39 t. | 1 |
| 2021 | - | -23 t. | -24 t. | 54 t. | 1 |
| 2020 | - | -18 t. | -18 t. | 79 t. | 1 |
| 2019 | - | -48 t. | -49 t. | 97 t. | 1 |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
ENDOGEN ApS has published its annual report for 2022. Gross profit came to DKK -15,310, and the net result was DKK -15,405.
About ENDOGEN ApS
ENDOGEN ApS is a Danish company of the type Anpartsselskab based in Aarhus C, founded in 2008. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Simon Glerup Pedersen. The company is owned by KOLLISION ApS, Camilla Gustafsen Consulting ApS and Simon Glerup Consulting ApS. In 2025, the company reported a gross profit of DKK 113,212 and a net result of DKK -79,499 compared with DKK -22,939 the year before. Equity amounted to DKK -82,428.